Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Kranaster

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Neuroscience Letters|April 13, 2019
Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levelsLaura Kranaster, Rainer Hellweg, Alexander Sartorius
European Archives of Psychiatry and Clinical Neuroscience|December 12, 2018
A novel seizure quality index based on ictal parameters for optimizing clinical decision-making in electroconvulsive therapy. Part 2: ValidationLaura Kranaster, Christine Jennen-Steinmetz, Alexander Sartorius
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 9, 2012
Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophreniaLaura Kranaster, Carolin Hoyer, Christoph Janke, et al.
Journal of Affective Disorders|May 20, 2019
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot studyLaura Kranaster, Kaj Blennow, Henrik Zetterberg, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 25, 2017
Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depressionLaura Kranaster, Kaj Blennow, Henrik Zetterberg, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 10, 2013
Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective studyCarolin Hoyer, Laura Kranaster, Christoph Janke, et al.
The Journal of ECT|May 25, 2012
Management of severe postictal agitation after electroconvulsive therapy with bispectrum electroencephalogram index monitoring: a case reportLaura Kranaster, Christoph Janke, Carolin Hoyer, et al.
Neuropsychiatric Disease and Treatment|July 17, 2019
Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute strokeCarolin Hoyer, Hanna Luise Schmidt, Laura Kranaster, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 15, 2011
Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective studyLaura Kranaster, Jutta Kammerer-Ciernioch, Carolin Hoyer, et al.
The Journal of ECT|January 11, 2013
Burst suppression: a more valid marker of postictal central inhibition?Laura Kranaster, Peter Plum, Carolin Hoyer, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|April 13, 2019
Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levelsLaura Kranaster, Rainer Hellweg, Alexander Sartorius
European Archives of Psychiatry and Clinical Neuroscience|December 12, 2018
A novel seizure quality index based on ictal parameters for optimizing clinical decision-making in electroconvulsive therapy. Part 2: ValidationLaura Kranaster, Christine Jennen-Steinmetz, Alexander Sartorius
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 9, 2012
Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophreniaLaura Kranaster, Carolin Hoyer, Christoph Janke, et al.
Journal of Affective Disorders|May 20, 2019
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot studyLaura Kranaster, Kaj Blennow, Henrik Zetterberg, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 25, 2017
Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depressionLaura Kranaster, Kaj Blennow, Henrik Zetterberg, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 10, 2013
Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective studyCarolin Hoyer, Laura Kranaster, Christoph Janke, et al.
The Journal of ECT|May 25, 2012
Management of severe postictal agitation after electroconvulsive therapy with bispectrum electroencephalogram index monitoring: a case reportLaura Kranaster, Christoph Janke, Carolin Hoyer, et al.
Neuropsychiatric Disease and Treatment|July 17, 2019
Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute strokeCarolin Hoyer, Hanna Luise Schmidt, Laura Kranaster, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 15, 2011
Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective studyLaura Kranaster, Jutta Kammerer-Ciernioch, Carolin Hoyer, et al.
The Journal of ECT|January 11, 2013
Burst suppression: a more valid marker of postictal central inhibition?Laura Kranaster, Peter Plum, Carolin Hoyer, et al.
Pageof 6